[1] Li Y, Chen C, Ma Y, et al.Multi-system reproductive metabolic disorder:significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS)[J].Life Sci,2019,228:167-175. [2] 中华医学会妇产科学分会内分泌学组及指南专家组.多囊卵巢综合征中国诊疗指南[J].中华妇产科杂志, 2018, 53 (1) :2-6. [3] Gourgari E, Spanakis E, Dobs A S.Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome[J].Int J Womens Health, 2016,8:381-387. [4] 武红琴,阮祥燕,卢永军, 等.多囊卵巢综合征患者合并代谢综合征的患病率和预测指标[J].首都医科大学学报,2015,36(4):553-558. [5] Huang R, Zheng J, Li S, et al.Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome[J].Acta Obstet Gynecol Scand,2015,94(5):494-500. [6] 王景尚,孙明月,黄烨,等.α-硫辛酸对血糖波动状态下2型糖尿病大鼠血管内皮细胞功能及PI3K/Akt/GSK-3β通路的影响[J].中国全科医学,2017, 20(24):2965-2971. [7] 李光伟.胰岛素抵抗评估及其临床应用[J].中华老年多器官疾病杂志, 2004, 3(1):11-12. [8] Azziz R.Polycystic ovary syndrome[J].Obstet Gynecol, 2018,132(2):321-336. [9] Wang J, Wu D, Guo H, et al.Hyperandrogenemia and insulin resistance:the chief culprit of polycystic ovary syndrome[J].Life Sci, 2019,236:116940. [10] Maliqueo M, Benrick A, Stener-Victorin E.Rodent models of polycystic ovary syndrome:phenotypic presentation, pathophysiology, and the effects of different interventions[J].Semin Reprod Med, 2014, 32(3):183-193. [11] 曾蕾,赵红艳,罗颂平.改良PCOS-IR大鼠模型的设计与实验[J].中华中医药杂志,2010,25(12):2341-2345. [12] 赖毛华,马红霞,郑艳华,等.PCOS-IR大鼠动物模型的构建与评价[J].云南中医中药杂志,2014,35(9):69-71. [13] 魏巍,徐泰安,王秋实,等.两种多囊卵巢综合征伴胰岛素抵抗大鼠模型的比较研究[J].哈尔滨医科大学学报,2019, 53(1):12-16. [14] 蔡云,许昕.来曲唑联合高脂饲料建立PCOS-IR大鼠模型实验研究[J].首都医科大学学报,2017,38(2):244-248. [15] 王明星,尹谦,张晓丹, 等.来曲唑联合高脂膳食诱导PCOS-IR大鼠模型复制时间及其内分泌、代谢改变的实验研究[J].中国现代医学杂志,2020,30(1):1-7. [16] 林莺,张宏,黄鸣清,等.来曲唑配合高脂膳食诱导胰岛素抵抗多囊卵巢综合征大鼠代谢表型的实验研究[J].中国现代医学杂志,2016,26(3):9-13. [17] 刘艳丽,贾莉婷,马葆靖,等.来曲唑法建立PCOS大鼠模型的评价[J].中国妇幼保健,2011,26(8):1213-1216. |